DNASequence is pleased to announce the conclusion of an agreement with the Central Markets & Fishery Organization S.A..The aim of this pilot project is to detect and record the microbial footprint in the Piraeus Fish Market and the Athens Central Market, with emphasis on the identification of pathogens associated with the occurrence of infections.


DNASequence is pleased to announce its partnership with the Engineers and Public Works Contractors Fund (TMEDE N.I.P.I.) for implementing biosafety control at the TMEDE Headquarters. The primary goal of this pilot project is to document the microbial footprint within the TMEDE Head Offices, emphasizing the identification of pathogens associated with the occurrence of infections. 

We are pleased to announce that DNA Sequence has been honored as an innovative company in the 5th "Thales the Milesios" Business Awards - Ode to Innovation.

The award in the "Health" category was presented by the Deputy Minister of Health, Dimitris Vartzopoulos, to Christos Karapiperis, co-founder and CTO of DNA Sequence.

The awards were given to Greek companies that stand out in the field of innovation and managed to revolutionize their sector, significantly enhancing the transformation of the Greek Economy.


DNA Sequence SRL is pleased to announce the realization of a Biosafety audit with Metagenomics at the Athens Naval Hospital. The audit and sampling was carried out with great success in catering areas. Our company would like to thank the management and staff of the Athens Naval Hospital, for the cooperation and the trust shown in our technology and our qualified staff.
DNA Sequence in Build Constructive News with a feature on Biosafety.

Τwo excellent articles by professor Christos Ouzounis and  Dr. Aspasia Chatziefthimiou (pages 4-6, 8).

Build is a daily e-newsletter covering Construction, Architecture and Design, Real Estate, Infrastructure and major investment projects.